JP2017517257A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017517257A5 JP2017517257A5 JP2016568644A JP2016568644A JP2017517257A5 JP 2017517257 A5 JP2017517257 A5 JP 2017517257A5 JP 2016568644 A JP2016568644 A JP 2016568644A JP 2016568644 A JP2016568644 A JP 2016568644A JP 2017517257 A5 JP2017517257 A5 JP 2017517257A5
- Authority
- JP
- Japan
- Prior art keywords
- protein
- dna sequence
- negative strain
- effector protein
- proteins
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP14169335.8 | 2014-05-21 | ||
| EP14169335 | 2014-05-21 | ||
| PCT/EP2015/061086 WO2015177197A1 (en) | 2014-05-21 | 2015-05-20 | Bacteria-based protein delivery |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020121375A Division JP2020182478A (ja) | 2014-05-21 | 2020-07-15 | 細菌に基づくタンパク質送達 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017517257A JP2017517257A (ja) | 2017-06-29 |
| JP2017517257A5 true JP2017517257A5 (enExample) | 2018-06-28 |
| JP6797025B2 JP6797025B2 (ja) | 2020-12-09 |
Family
ID=50771120
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016568644A Active JP6797025B2 (ja) | 2014-05-21 | 2015-05-20 | 細菌に基づくタンパク質送達 |
| JP2020121375A Withdrawn JP2020182478A (ja) | 2014-05-21 | 2020-07-15 | 細菌に基づくタンパク質送達 |
| JP2022069709A Active JP7509821B2 (ja) | 2014-05-21 | 2022-04-20 | 細菌に基づくタンパク質送達 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020121375A Withdrawn JP2020182478A (ja) | 2014-05-21 | 2020-07-15 | 細菌に基づくタンパク質送達 |
| JP2022069709A Active JP7509821B2 (ja) | 2014-05-21 | 2022-04-20 | 細菌に基づくタンパク質送達 |
Country Status (23)
| Country | Link |
|---|---|
| US (3) | US10889823B2 (enExample) |
| EP (2) | EP3660034A1 (enExample) |
| JP (3) | JP6797025B2 (enExample) |
| KR (2) | KR102648293B1 (enExample) |
| CN (2) | CN115960919A (enExample) |
| AU (1) | AU2015261905B2 (enExample) |
| BR (1) | BR112016027196B1 (enExample) |
| CA (1) | CA2948570C (enExample) |
| CY (1) | CY1122701T1 (enExample) |
| DK (1) | DK3145946T3 (enExample) |
| EA (1) | EA201692025A1 (enExample) |
| ES (1) | ES2754508T3 (enExample) |
| HR (1) | HRP20192050T1 (enExample) |
| HU (1) | HUE046025T2 (enExample) |
| IL (2) | IL248827B (enExample) |
| LT (1) | LT3145946T (enExample) |
| PL (1) | PL3145946T3 (enExample) |
| PT (1) | PT3145946T (enExample) |
| RS (1) | RS59583B1 (enExample) |
| SG (1) | SG11201609629YA (enExample) |
| SI (1) | SI3145946T1 (enExample) |
| SM (1) | SMT201900626T1 (enExample) |
| WO (1) | WO2015177197A1 (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102648293B1 (ko) | 2014-05-21 | 2024-03-15 | 우니페르시테트 바젤 | 세균 기반 단백질 전달 |
| IL259050B2 (en) * | 2015-11-19 | 2024-03-01 | Univ Basel | Bacteria-based protein delivery |
| EP3377094B1 (en) | 2015-11-19 | 2021-04-28 | Universität Basel | Virulence attenuated bacteria for treatment of malignant solid tumors |
| US12351805B2 (en) | 2015-11-19 | 2025-07-08 | Northeastern University | Method of making recombinant silk and silk-amyloid hybrid proteins using bacteria |
| WO2017087827A1 (en) * | 2015-11-19 | 2017-05-26 | President And Fellows Of Harvard College | Method of making recombinant silk andsilk-amyloid hybrid proteins using bacteria |
| EP3957645A1 (en) * | 2016-12-20 | 2022-02-23 | Universität Basel | Virulence attenuated bacteria based protein delivery |
| WO2018183850A2 (en) * | 2017-03-31 | 2018-10-04 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Methods, systems, and compositions for inhibiting virulance of a/e family pathogens |
| CN107858367A (zh) * | 2017-12-05 | 2018-03-30 | 复旦大学附属肿瘤医院 | 一种利用细菌靶向投递治疗性蛋白的系统及其应用 |
| CN114401730A (zh) * | 2019-05-01 | 2022-04-26 | 因内特生物制品有限责任公司 | 免疫调节组合物和方法 |
| US20220362361A1 (en) * | 2019-10-18 | 2022-11-17 | University Of Virginia Patent Foundation | Compositions and methods for producing enhanced immune responses and rapid antibody production |
| CN111848803B (zh) * | 2020-07-21 | 2022-04-08 | 珠海中科先进技术研究院有限公司 | 一种具有突出酸碱稳定性的磷脂酰肌醇蛋白聚糖3的纳米抗体及其制备方法 |
| WO2022087856A1 (zh) * | 2020-10-26 | 2022-05-05 | 南京吉芮康生物科技研究院有限公司 | 一种减毒沙门氏菌分泌表达rbd结构域蛋白的新型冠状病毒疫苗抗原递呈系统及其应用 |
| CN114712496B (zh) * | 2022-04-29 | 2023-10-13 | 中山大学·深圳 | 一种展示新抗原的细菌衍生外膜囊泡疫苗及制备方法和在制备癌症免疫治疗试剂盒中的应用 |
| CN115896314A (zh) * | 2022-07-14 | 2023-04-04 | 四川大学 | 一种基于lf-rpa的猕猴桃细菌性溃疡病菌的无设备、可视化检测方法 |
| CN117511912B (zh) * | 2023-12-22 | 2024-03-29 | 辉大(上海)生物科技有限公司 | IscB多肽、包含其的系统及其用途 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5965381A (en) * | 1998-03-06 | 1999-10-12 | Ludwig Institute For Cancer Research | Delivery of proteins into eukaryotic cells with recombinant yersinia |
| WO2000002996A2 (en) * | 1998-07-10 | 2000-01-20 | Cornell Research Foundation, Inc. | Recombinant constructs and systems for secretion of proteins via type iii secretion systems |
| AU2001294834A1 (en) | 2000-09-26 | 2002-04-08 | Beth Israel Deaconess Medical Center | Recombinant bcg vaccines for the prevention and treatment of cancer |
| WO2002077249A2 (en) | 2001-03-26 | 2002-10-03 | Universite Catholique De Louvain | Type iii bacterial strains for use in medicine |
| FR2862312B1 (fr) * | 2003-11-13 | 2006-02-17 | Univ Grenoble 1 | Outil de transfert et de production de proteines mettant en oeuvre le systeme de secretion de type iii de pseudomonas |
| CN101738822A (zh) | 2005-07-15 | 2010-06-16 | 莱尔德科技Map有限公司 | 小型摄像机用开闭装置 |
| EP1943344A2 (en) | 2005-10-04 | 2008-07-16 | The Ludwig Institute for Cancer Research | Methods for stimulating an immune response using bacterial antigen delivery system |
| WO2008019183A2 (en) * | 2006-05-18 | 2008-02-14 | The Regents Of The University Of California | Biopolymer and protein production using type iii secretion systems of gram negative bacteria |
| TW200819540A (en) | 2006-07-11 | 2008-05-01 | Genelux Corp | Methods and compositions for detection of microorganisms and cells and treatment of diseases and disorders |
| EP1921149A1 (en) * | 2006-11-13 | 2008-05-14 | AEterna Zentaris GmbH | Microorganisms as carriers of nucleotide sequences coding for antigens and protein toxins, process of manufacturing and uses thereof |
| EP2268313A2 (en) | 2008-03-17 | 2011-01-05 | Universitätsklinikum Münster | Yopm as delivery vehicle for cargo molecules and as biological therapeutic for immunomodulation of inflammatory reactions |
| GB2483595B (en) * | 2009-05-22 | 2017-03-29 | The Arizona Board Of Regents For And On Behalf Of Arizona State Univ | Recombinant bacterium and methods of antigen and nucleic acid delivery |
| EP3049526B1 (en) | 2013-09-24 | 2021-02-24 | Medicenna Therapeutics, Inc. | Interleukin-4 receptor-binding fusion proteins and uses thereof |
| US10143743B2 (en) | 2013-11-18 | 2018-12-04 | Yale University | Non-replicating bacterial nanoparticle delivery system and methods of use |
| KR102648293B1 (ko) | 2014-05-21 | 2024-03-15 | 우니페르시테트 바젤 | 세균 기반 단백질 전달 |
| EP3377094B1 (en) | 2015-11-19 | 2021-04-28 | Universität Basel | Virulence attenuated bacteria for treatment of malignant solid tumors |
| IL259050B2 (en) | 2015-11-19 | 2024-03-01 | Univ Basel | Bacteria-based protein delivery |
| EP3957645A1 (en) | 2016-12-20 | 2022-02-23 | Universität Basel | Virulence attenuated bacteria based protein delivery |
-
2015
- 2015-05-20 KR KR1020227030220A patent/KR102648293B1/ko active Active
- 2015-05-20 CN CN202211325325.8A patent/CN115960919A/zh active Pending
- 2015-05-20 WO PCT/EP2015/061086 patent/WO2015177197A1/en not_active Ceased
- 2015-05-20 HU HUE15725282A patent/HUE046025T2/hu unknown
- 2015-05-20 HR HRP20192050TT patent/HRP20192050T1/hr unknown
- 2015-05-20 JP JP2016568644A patent/JP6797025B2/ja active Active
- 2015-05-20 AU AU2015261905A patent/AU2015261905B2/en active Active
- 2015-05-20 EP EP19191383.9A patent/EP3660034A1/en active Pending
- 2015-05-20 SG SG11201609629YA patent/SG11201609629YA/en unknown
- 2015-05-20 PT PT157252826T patent/PT3145946T/pt unknown
- 2015-05-20 CN CN201580040391.2A patent/CN107001431B/zh active Active
- 2015-05-20 ES ES15725282T patent/ES2754508T3/es active Active
- 2015-05-20 PL PL15725282T patent/PL3145946T3/pl unknown
- 2015-05-20 EA EA201692025A patent/EA201692025A1/ru unknown
- 2015-05-20 LT LT15725282T patent/LT3145946T/lt unknown
- 2015-05-20 CA CA2948570A patent/CA2948570C/en active Active
- 2015-05-20 EP EP15725282.6A patent/EP3145946B1/en active Active
- 2015-05-20 SI SI201530993T patent/SI3145946T1/sl unknown
- 2015-05-20 BR BR112016027196-3A patent/BR112016027196B1/pt active IP Right Grant
- 2015-05-20 DK DK15725282T patent/DK3145946T3/da active
- 2015-05-20 RS RS20191450A patent/RS59583B1/sr unknown
- 2015-05-20 SM SM20190626T patent/SMT201900626T1/it unknown
- 2015-05-20 US US15/311,424 patent/US10889823B2/en active Active
- 2015-05-20 KR KR1020167035405A patent/KR102440293B1/ko active Active
-
2016
- 2016-11-08 IL IL248827A patent/IL248827B/en unknown
-
2019
- 2019-11-01 CY CY20191101138T patent/CY1122701T1/el unknown
-
2020
- 2020-07-15 JP JP2020121375A patent/JP2020182478A/ja not_active Withdrawn
- 2020-12-03 US US17/111,332 patent/US12091670B2/en active Active
-
2021
- 2021-05-19 IL IL283280A patent/IL283280B2/en unknown
-
2022
- 2022-04-20 JP JP2022069709A patent/JP7509821B2/ja active Active
-
2024
- 2024-08-15 US US18/806,599 patent/US20240401065A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017517257A5 (enExample) | ||
| HRP20192050T1 (hr) | Isporuka proteina na bazi bakterija | |
| JP2016518833A5 (enExample) | ||
| Martin et al. | Staphylococcus aureus activates type I IFN signaling in mice and humans through the Xr repeated sequences of protein A | |
| Wei et al. | Facilitation of expression and purification of an antimicrobial peptide by fusion with baculoviral polyhedrin in Escherichia coli | |
| AR108442A1 (es) | Proteínas de fusión gdf15 y usos de estas | |
| Ollis et al. | Cytoplasmic membrane protonmotive force energizes periplasmic interactions between ExbD and TonB | |
| MX387465B (es) | Marcas genéticas de transgenes y métodos de uso. | |
| JP2005120106A5 (enExample) | ||
| WO2014172631A4 (en) | Expression of biologically active proteins in a bacterial cell-free synthesis system using cell extracts with elevated levels of exogenous chaperones | |
| JP2014503198A5 (enExample) | ||
| EA201892554A1 (ru) | Мутант cd200 и его применения | |
| JP2015523066A5 (enExample) | ||
| CN110036108A (zh) | 一种细菌β-1,3-葡聚糖酶及其编码基因与应用 | |
| JP2016520531A5 (enExample) | ||
| JP2017529868A5 (enExample) | ||
| WO2020102642A8 (en) | Endospore display platforms, products and methods | |
| Zelena et al. | Escherichia coli as a production host for novel enzymes from basidiomycota | |
| WO2008033451A3 (en) | Protein aggregation domains from prions and methods of use thereof | |
| Orrapin et al. | Recombinant expression of novel protegrin-1 dimer and LL-37-linker–histatin-5 hybrid peptide mediated biotin carboxyl carrier protein fusion partner | |
| JP2015536347A5 (enExample) | ||
| GB201102700D0 (en) | Protein secretion | |
| JP2015510770A5 (enExample) | ||
| NO20085201L (no) | Rekombinante novirhabdoviruser og deres anvendelse | |
| CN103910785B (zh) | 一种荧光假单胞菌TonB依赖型外膜受体及其应用 |